Gts Securities LLC Ocugen, Inc. Call Options Transaction History

Gts Securities LLC

  • $54.2 Billion
  • Q1 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024
SELL
$0.5 - $1.83 $2,100 - $7,686
-4,200 Reduced 12.03%
30,700 $50,000
Q4 2023

Feb 14, 2024
SELL
$0.36 - $0.57 $2,232 - $3,533
-6,200 Reduced 15.09%
34,900 $19,000
Q3 2023

Nov 15, 2023
BUY
$0.4 - $0.62 $16,440 - $25,482
41,100 New
41,100 $16,000

Others Institutions Holding OCGN

# of Institutions
88
Shares Held
32.8M
Call Options Held
518K
Put Options Held
345K
View Full List

About Ocugen, Inc.

OCGN Quotes by TradingView
  • Ticker OCGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,566,000
  • Market Cap $349M
  • Description
  • Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...
More about OCGN
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email